News

Though its accompanying album might again be subject to a sense of mystery, "Bluebird" proves Lana Del Rey knows exactly what she's doing in her new era. By Tyler Jenke Lana Del Rey fans have ...
Del Rey, 39, recounted the unique inspiration for the ethereal ballad, which thematically uses the titular bluebird as a metaphor for self-healing. She improvised the melody when a bird flew into ...
By McKinley Franklin Lana Del Rey’s new song, “Bluebird,” is out. The American singer-songwriter dropped her latest track Friday, the second single off her upcoming 10th studio album.
Lana Del Rey’s Southern-inspired era is officially here thanks to her track, “Bluebird.” Written by Lana and Luke Laird, the song showcases the singer as she finds strength and encourages ...
On Friday, April 18, the "Young and Beautiful" singer released the single "Bluebird." It is a dreamy song about hope and self-healing, timed perfectly for springtime's arrival. "Your crash landing ...
Now, she’s unveiling “Bluebird.” The LP was originally slated for release by the end of 2024, and then it was set for May 21. We don’t know when it’s coming, nor do we know its new title.
It’s looking like a Lana Del Rey summer. After the songstress shared “Henry, come on” last Friday, she followed it up with “Bluebird,” another reflective ballad. “Henry, come on ...
SOMERVILLE, Mass. - bluebird bio, Inc. (NASDAQ: BLUE), currently trading at $4.47 and carrying a substantial debt burden of $370.53 million, has reaffirmed its Board of Directors’ unanimous ...
Lana Del Rey has shared ‘Bluebird’, thought to be the second single from her upcoming as-yet-untitled new album. The acoustic ballad was co-written with country musician Luke Laird and ...
When Kishimoto returned to writing duties in Boruto: Naruto Next Generations, he threw everything out of whack by killing the Nine-Tailed Fox and Jigen, making major changes to the shonen landscape.
The latest trading day saw Blue Bird (BLBD) settling at $33.24, representing a -1.38% change from its previous close. We recently published a list of 11 Best Russell 2000 Stocks to Buy According ...
Bluebird’s lead CAR-T cancer cell therapy idecabtagene vicleucel (ide-cel) was last year hit with an FDA refuse-to-file letter, which required additional data on chemistry, manufacturing and ...